Download PDF
Thromb Haemost 1976; 36(01): 014-026
DOI: 10.1055/s-0038-1648005
Original Article
Schattauer GmbH

Molecular Size Distribution of Fibrinogen Derivatives Formed in Vitro and in Vivo: a Chromatographic Study

M. B Donati   *
1   Laboratory of Blood Coagulation, Medical Research Department, University of Leuven, Belgium
,
R Verhaeghe
1   Laboratory of Blood Coagulation, Medical Research Department, University of Leuven, Belgium
,
D. E Culasso   **
1   Laboratory of Blood Coagulation, Medical Research Department, University of Leuven, Belgium
,
J Vermylen
1   Laboratory of Blood Coagulation, Medical Research Department, University of Leuven, Belgium
› Author Affiliations
Further Information

Publication History

Received 25 September 1975

Accepted 02 April 1976

Publication Date:
03 July 2018 (online)

Also available at
    Permissions and Reprints

Summary

Using gel chromatography, fibrinogen derivatives present in purified systems or in biological fluids were separated and partially characterized. Eight groups of fibrinogen derivatives could be separated by gel filtration through 6% agarose in large columns, four with an elution volume smaller and four groups with an elution volume larger than that of fibrinogen. Careful calibration of the column allowed estimation of the diffusion coefficients of some of the derivatives and, thus, comparison with derivatives previously identified. Three, rather than two, groups of intermediate derivatives were observed during the degradation of human fibrinogen by plasmin in vitro or in vivo. One of these had a marked tendency to polymerize.

A rather distinct difference in elution pattern was found between plasma obtained during streptokinase administration and from patients with intravascular coagulation.

* Present address: Laboratory for Haemostasis and Thrombosis Research, ‘Mario Negri’ Institute, Via Eritrea, 62 – 20157 Milano, Italy.


** Present address: Avellaneda 2127, Cordoba, Argentina.


 

  • References

  • 1 Alkjaersig N, Fletcher A. P, Sherry S. 1962; Pathogenesis of the coagulation defect developing in pathological plasma proteolytic (“fibrinolytic”) states. II. The significance, mechanism and consequences of defective fibrin polymerization. Journal of Clinical Investigation 41: 917.
    CrossrefPubMedSearch in Google Scholar
  • 2 Alkjaersig N, Vermylen J, Fletcher A. P. 1969; Fibrinogen proteolysis in vitro by plasmin. Federation Proceedings 28: 640.
    PubMedSearch in Google Scholar
  • 3 Allison A. C, Humphrey J. H. 1960; A theoretical and experimental analysis of double diffusion precipitate reactions in gels, and its application to characterization of antigens. Immunology 3: 95.
    PubMedSearch in Google Scholar
  • 4 Andrews P. 1965; The gel-filtration behaviour of proteins related to their molecular weights over a wide range. Biochemical Journal 96: 595.
    CrossrefPubMedSearch in Google Scholar
  • 5 Blättler W, Straub P. W, Peyer A. 1974; Effect of in vivo produced fibrinogen-fibrin intermediates on viscosity of human blood. Thrombosis Research 4: 787.
    CrossrefPubMedSearch in Google Scholar
  • 6 Blombäck B, Blombäck M, Finkbeiner W, Holmgren A, Kowalska-Loth B, Olovson G. 1974; Enzymatic reduction of disulfide bonds in fibrinogen by the thioredoxin system. I. Identification of reduced bonds and studies of reoxidation process. Thrombosis Research 4: 55.
    CrossrefPubMedSearch in Google Scholar
  • 7 Blombäck M. 1958; Purification of antihemophilic globulin. I. Stability of antihemophilic globulin activity in fraction I-O and a method for its partial separation from fibrinogen. Arkiv for Kemi 12: 387.
    PubMedSearch in Google Scholar
  • 8 Collen D, Tytgat G. N, Claeys H, Piessens R. 1972; Metabolism and distribution of fibrinogen. I. Fibrinogen turnover in physiological conditions in humans. British Journal of Haematology 22: 681.
    CrossrefPubMedSearch in Google Scholar
  • 9 de Gaetano G, Donati M. B, Vermylen J. 1971; Human platelet clumping by bovine fibrinogen during its degradation. Scandinavian Journal of Haematology, Supplement 13: 281.
    PubMedSearch in Google Scholar
  • 10 Donati M. B, Molla A, Vermylen J. 1971; The tanned red cell hemagglutination inhibition immunoassay and purified fibrinogen degradation products. Scandinavian Journal of Haematology Supplement 13: 91.
    PubMedSearch in Google Scholar
  • 11 Fisher S, Fletcher A. P, Alkjaersig N, Sherry S. 1967; Immunoelectrophoretic characterization of plasma fibrinogen derivatives in patients with pathological plasma proteolysis. Journal of Laboratory and Clinical Medicine 70: 903.
    PubMedSearch in Google Scholar
  • 12 Fletcher A. P. 1970; Fibrinogen proteolysis in vivo. Thrombosis et Diathesis Haemorrhagica, Supplement 39: 249.
    PubMedSearch in Google Scholar
  • 13 Fletcher A. P, Alkjaersig N. 1970; Blood hypercoagulability and thrombosis. Clinical Research 18: 531.
    PubMedSearch in Google Scholar
  • 14 Fletcher A. P, Alkjaersig N. 1973. Laboratory diagnosis of intravascular coagulation. In: Poller L. (ed.), Recent Advances in Thrombosis. Churchill Livingstone; Edinburgh: 87.
    Search in Google Scholar
  • 15 Fletcher A. P, Alkjaersig N, Fisher S, Sherry S. 1966; The proteolysis of fibrinogen by plasmin: The identification of thrombin-clottable fibrinogen derivatives which polymerize abnormally. Journal of Laboratory and Clinical Medicine 68: 780.
    PubMedSearch in Google Scholar
  • 16 Gaffney P. J. 1973; The molecular and functional condition of plasma fibrinogen during thrombolytic therapy with streptokinase (SK). Thrombosis Research 2: 105.
    CrossrefPubMedSearch in Google Scholar
  • 17 Graeff H, von Hugo R. 1972; Identification of fibrinogen derivatives in plasma samples. Thrombosis et Diathesis Haemorrhagica 27: 610.
    PubMedSearch in Google Scholar
  • 18 Latallo Z. S, Teisseyre E. 1971; Practical method for separation of the active component from a mixture of early fibrinogen degradation products. Scandinavian Journal of Haematology, Supplement 13: 383.
    PubMedSearch in Google Scholar
  • 19 Lipinski B, Wegrzynowicz Z, Budzynsky A. Z, Kopec M, Latallo Z. S, Kowalski E. 1967; Soluble unclottable complexes formed in the presence of fibrinogen degradation products (FDP) during the fibrinogen-fibrin conversion and their potential significance in pathology. Thrombosis et Diathesis Haemorrhagica 17: 65.
    PubMedSearch in Google Scholar
  • 20 Mancini G, Carbonara O, Heremans J. F. 1965; Immuno chemical quantitation of antigens by single radial immunodiffusion. Immunochemistry 2: 235.
    CrossrefPubMedSearch in Google Scholar
  • 21 Marder V. J, Shulman N. R. 1969; High molecular weight derivatives of human fibrinogen produced by plasmin. II. Mechanism of their anticoagulant activity. Journal of Biological Chemistry 244: 2120.
    PubMedSearch in Google Scholar
  • 22 Marder V. J, Shulman N. R, Carroll W. R. 1969; High molecular weight derivatives of human fibrinogen produced by plasmin. I. Physicochemical and immunological characterization. Journal of Biological Chemistry 244: 2111.
    PubMedSearch in Google Scholar
  • 23 Merskey C, Lalezari P, Johnson A. J. 1969; A rapid, simple, sensitive method for measuring fibrinolytic split products in human serum. Proceedings of the Society for Experimental Biology and Medicine 737: 871.
    PubMedSearch in Google Scholar
  • 24 Sasaki T, Page I. H, Shainoff J. R. 1966; Stable complex of fibrinogen and fibrin. Science (Washington) 152: 1069.
    CrossrefPubMedSearch in Google Scholar
  • 25 Shainoff J. R, Page I. H. 1962; Significance of cryoprofibrin in fibrinogen-fibrin conversion. Journal of Experimental Medicine 116: 687.
    CrossrefPubMedSearch in Google Scholar
  • 26 Smith G. F, Bang N. U. 1972; Formation of soluble fibrin polymers. Fibrinogen degradation fragments D and E fail to form soluble complexes with fibrin monomer. Biochemistry 11: 2958.
    CrossrefPubMedSearch in Google Scholar
  • 27 Stewart G. J, Niewarowski S. 1969; Nonezymatic polymerization of fibrinogen by protamine sulfate. An electron microscope study. Biochimica Biophysica Acta 194: 462.
    CrossrefPubMedSearch in Google Scholar
  • 28 Vermylen J, Donati M. B, Verstraete M. 1971; The identification of fibrinogen derivatives in plasma and serum by agarose gel filtration. Scandinavian Journal of Haematology, Supplement 13: 219.
    PubMedSearch in Google Scholar
  • 29 Verstraete M, Vermylen J, Donati M. B. 1971a The effect of streptokinase infusion on chronic arterial occlusions and stenoses. Annals of Internal Medicine 74: 377.
    PubMed
  • 30 Verstraete M, Vermylen J, Donati M. B. (eds.) 1971b Fibrinogen Degradation Products. Scandinavian Journal of Haematology. Supplement 73.
    PubMed
  • 31 von Hugo R, Graeff H. 1973; Fibrin-I degradation products with a molecular weight higher than that of fibrinogen. Identification and characterization of in vitro products from human plasma. Thrombosis et Diathesis Haemorrhagica 29: 122.
    PubMedSearch in Google Scholar